Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ara Cell Zist Daru is a biotechnology company based in Iran that focuses on the development and production of cell-based medicinal products. The company specializes in regenerative medicine, offering autologous cell therapies for dermatological conditions such as vitiligo and skin aging, as well as orthopedic applications like osteoarthritis. Their product portfolio includes Ricell and Renocell, which utilize melanocytes and fibroblasts respectively for tissue repair. Ara Cell operates a GMP-compliant facility for cell processing and is a key player in the Iranian regenerative medicine sector. The company works closely with research institutions to advance the clinical application of stem cell technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aracell zist daru.